A Study of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants
Condition: Uterine Hemorrhage Interventions: Drug: Direct oral anticoagulant (DOACs); Drug: Warfarin Sponsor: Janssen Research & Development, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials